Application no. and date | 12708672.6 (espacenet) (Federated) (European Patent Register), 20120302 | Patent/reg. no. and date | DK/EP 2680832, 20190904 | Publication date | 20140108 | Priority no. and date | US 201161449287 P, 20110304, EP 11003601, 20110503 | EP pub. no. and date |
EP 2680832 20140108 | Effective date | | Applicant/owner | Grünenthal GmbH, Zieglerstrasse 6
52078 Aachen, DE | Applicant ref. no. | T6069_DK | Inventor | Reinhold, Ulrich, I. Rote-Haag Weg 44a
52076 Aachen, DE, SCHILLER, Marc, Max-Pechstein-Strasse 4
52076 Aachen, DE, INGHELBRECHT, Sabine, Karine, Katrien, c/o Janssen Pharmaceutica NV Turnhoutseweg 30
B-2340 Beerse, BE, EMBRECHTS, Roger, Carolus, Augusta, c/o Janssen Pharmaceutica NV Turnhoutseweg 30
B-2340 Beerse, BE, WULSTEN, Eva, Bonnenring 188
47877 Willich, DE, FEIL, Ulrich, Berliner Allee 17
63739 Aschaffenburg, DE | Representative | Orsnes Patent ApS, Sentvedvej 23, 5853 Ørbæk, DK | Opponent | | IPC Class | A61K 31/137 (2006.01) , A61K 47/02 (2006.01) , A61K 47/12 (2006.01) , A61K 9/08 (2006.01) , A61P 25/04 (2006.01) | Title | VANDIG FARMACEUTISK FORMULERING AF TAPENTADOL TIL ORAL ADMINISTRATION | Int. application no. | EP2012000904 | Int. publication no. | WO2012119727 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|